Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non‐small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapy-Reference-Cited by-同舟云学术

Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non‐small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapy

Published:2023-05-30 Issue:6 Volume:13 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Chu Tianqing¹,Yuan Jie²,Lu Jun¹³⁴⁵,Nie Wei¹,Zhong Runbo¹,Zhang Bo¹^ORCID,Zhang Wei¹,Shi Chunlei¹,Qian Jialin¹,Zhang Yanwei¹,Zhang Xueyan¹,Teng Jiajun¹,Gao Zhiqiang¹,Lou Yuqing¹,Li Jiaqi¹,Qiang Huiping¹,Zhang Chao²,Li Jin²,Xia Xuefeng⁶,Zhong Hua¹,Han Baohui¹

Affiliation:

1. Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

2. Geneplus‐Shenzhen Shenzhen China

3. Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

4. Translational Medical Research Platform for Thoracic Oncology, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

5. Department of Bio‐Bank, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

6. Geneplus‐Beijing Beijing China

Funder

Shanghai Chest Hospital

National Natural Science Foundation of China

Shanghai Jiao Tong University

Chinese Society of Clinical Oncology

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link